Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice

Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women

(2014) Jean-Claude Forest et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation

(2014) Santiago Garcia-Tizon Larroca et al.   FETAL DIAGNOSIS AND THERAPY

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

(2014) Jonathan Lai et al.   FETAL DIAGNOSIS AND THERAPY

A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation

(2014) Chikako Hirashima et al.   HYPERTENSION RESEARCH

Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida

(2014) Lalita Kulmala et al.   HYPERTENSION RESEARCH

Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles

(2014) Thushari I. Alahakoon et al.   Journal of Maternal-Fetal & Neonatal Medicine

Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction

(2014) Ignacio Herraiz et al.   OBSTETRICS AND GYNECOLOGY

The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia

(2014) Cilene Carlos Pinheiro et al.   PRENATAL DIAGNOSIS

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol

(2014) Martin Hund et al.   BMC Pregnancy and Childbirth

Prediction of preeclampsia and induced delivery at

(2014) Johannes Stubert et al.   BMC Pregnancy and Childbirth

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP

(2014) A.L. Tranquilli et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia

(2013) Tinnakorn Chaiworapongsa et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes

(2013) V. A. Holmes et al.   DIABETES CARE

New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia

(2013) Stefan Verlohren et al.   HYPERTENSION

Presymptomatic prediction of preeclampsia with angiogenic factors, in high risk pregnant women

(2013) Patrícia G. Teixeira et al.   HYPERTENSION IN PREGNANCY

Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study

(2013) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome

(2013) Wiebke Schaarschmidt et al.   JOURNAL OF PERINATAL MEDICINE

The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction

(2013) Katharina Schoofs et al.   JOURNAL OF PERINATAL MEDICINE

Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population

(2013) Caroline Diguisto et al.   PRENATAL DIAGNOSIS

Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia

(2013) P. I. Gómez-Arriaga et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia

(2013) P. I. Gómez-Arriaga et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Angiogenic factorsvsDoppler surveillance in the prediction of adverse outcome among late-pregnancy small-for- gestational-age fetuses

(2013) S. M. Lobmaier et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia

(2012) Alfredo Leaños-Miranda et al.   JOURNAL OF HYPERTENSION

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

(2012) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion

(2012) Eleazar Soto et al.   Journal of Maternal-Fetal & Neonatal Medicine

Can detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers?

(2012) Ines Kaufmann et al.   PRENATAL DIAGNOSIS

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

(2011) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia

(2011) Stefan Verlohren et al.   CLINICAL SCIENCE

Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia

(2010) J. Schiettecatte et al.   CLINICAL BIOCHEMISTRY

Relation Between Maternal Angiogenic Factors and Utero-Placental Resistance in Normal First- and Second-Trimester Pregnancies

(2010) Katrin Petzold et al.   HYPERTENSION IN PREGNANCY

Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia

(2010) Akihide Ohkuchi et al.   HYPERTENSION RESEARCH

An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study

(2010) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

(2009) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

(2009) Juan Pedro Kusanovic et al.   Journal of Maternal-Fetal & Neonatal Medicine

The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation

(2008) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine